-transparent.png){kind=logo}
Bupropion is a norepinephrine dopamine-reuptake inhibitor that has been found to be effective in the treatment of nicotine dependence. Although well tolerated, seizures and psychosis have been described to occur with bupropion as severe adverse effects. We report the precipitation of acute psychosis with bupropion prescribed for smoking cessation in an elderly patient.
Related Publications
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
November 2008,
Ugeskrift for laeger,
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
January 2010,
Primary care companion to the Journal of clinical psychiatry,
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
November 1952,
The American journal of psychiatry,
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
December 1979,
The British journal of psychiatry : the journal of mental science,
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
January 2005,
Progress in neuro-psychopharmacology & biological psychiatry,
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
April 1989,
Arquivos brasileiros de cardiologia,
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
December 1994,
East African medical journal,
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
January 2021,
General psychiatry,
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
May 2010,
Clinical toxicology (Philadelphia, Pa.),
Ravindra Neelakanthappa Munoli, and
Sreejayan Kongasseri, and
Samir Kumar Praharaj, and
Podila S V N Sharma
November 2004,
Psychiatrische Praxis,
